Expression of MiRNA-29b and MiRNA-31 and their diagnostic and prognostic values in Egyptian females with breast cancer.

For miR-29b, the survival analysis demonstrated that by the end of the 2 years follow-up period the survival rate there was a highly significant statistical difference in the survival rate among patients with a low miR-29b expression (96%) and patients with higher expression levels (64%) (Log-rank p < 0.001).

also in 132,142 other papers